AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

Inclusion Criteria:

Patients must meet the following inclusion criteria to participate in this study:

• Diagnosed by a physician and required a single or double mastectomy followed byPre-Pectoral Breast Reconstruction surgery with the use of AlloMend® AcellularDermal Matrix allograft;

• Surgical intervention using AlloMend® Acellular Dermal Matrix allograft was used;

• Has completed or will complete the anticipated clinically indicated follow-up visitsat 2 weeks, 6 weeks, 3 months, and 6 months post-surgical intervention.

Exclusion Criteria:

Patients must not meet any of the following criteria to be considered for this clinical trial:

• Did not utilize AlloMend® Acellular Dermal Matrix allograft during pre-pectoralbreast reconstruction

• Did not have post-operative evaluations at the clinical site.